Bio-Path 10K 2017 Annual report | BPTH Filing

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	H.S. freshman Avg

New words: adenocarcinoma, aDNAbilize®RNAi, antidilutive, antigen, AstraZeneca, attorney, Aubert, Aviragen, Babb, Baton, bid, carcinoma, cervical, circumstance, Colonnese, compressor, conventional, crossing, cum, daunorubicin, deficiency, deregulated, device, Dickinson, die, diem, dividend, Doctor, doubt, Eastern, embedded, error, exocrine, extinguished, extinguishment, Fairleigh, feature, fibrotic, forfeited, formula, fraught, gemcitabine, Gotshal, hampered, headquartered, Hedging, hypothesized, increasedpancreatic, incremental, indefinite, indefinitely, indolent, InNovember, isa, Ithaca, Jersey, Kurth, landscape, language, laude, leaving, lethal, Louisiana, magna, mandatorily, matrix, metastatic, mg, midostaurin, Muller, myelodysplasia, Mylotarg, nano, nanoparticle, NOL, noncontrolling, nonpublic, NSCLC, ozogamicin, pancreatic, particle, Paul, PC, PCAOB, PDAC, penetrate, penetrated, penetration, Pernix, precision, predecessor, preformed, Randolph, reclassification, reclassified, redeemable, regained, Restated, retroactively, RNAi, Roth, Rouge, round, Rydapt, Salutria, salvage, scar, screened, SD, settle, slim, split, Stealth, strike, stroma, synergistic, temporarily, thatwe, thrombocytopenia, Transgenomic, Tulane, unavailable, unconventional, unfavorable, unused, unusually, upstream, vesicle, Virginia, warranty, Weil, Winstead

Removed: Achillion, ACHN, Amherst, AMPE, Ampio, Amy, Assistant, assume, automatic, Avastin, awarded, BCRX, behavior, Bello, BioCryst, Biology, BioTime, BTX, cast, CEMP, Cempra, CEO, commitment, Composite, continuously, Cosmo, COSO, cumulative, Dell, dental, derivative, disability, discretionary, ECYT, effort, element, Endocyte, endorse, ensuring, favor, fourth, Fred, Genentech, Genomic, GERN, Geron, graph, guided, half, Harvard, hospital, Hutchinson, image, IMMU, industrial, inserted, invest, invested, involuntary, isolated, IST, ITT, larger, leader, MACK, marketplace, Mechanical, medicine, Medium, Merrimack, Mexico, Michael, Microbiology, mindful, molecular, Narrative, NEO, Nonqualified, occupied, OMER, opened, overwhelmingly, peer, percentile, personalized, plastic, prorated, Purdue, referenced, reflective, reinvestment, release, relied, representative, retirement, reward, rewarding, RPRX, School, Science, Sculpt, Seattle, SNTA, soliciting, Sono, spent, stake, Stanford, stay, succession, Synta, thereon, THLD, Threshold, tie, untaken, Verastem, vi, vote, VSTM, week, ZIOP, ZIOPHARM

Bio-Path (BPTH) 10-K2017 FY Annual report

Content analysis